This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Drug shortages have emerged as a significant global issue impacting patients worldwide.
Don’t be caught unprepared! Arm yourself with the knowledge and tools to identify and manage drug shortage risks with PDA’s newest course, Risk-Based Approach for Prevention and Management of Drug Shortages, taking place on May 13 at PDA's Training and Research Institute in Bethesda, Maryland and June 25 in Brussels, Belgium.
Risk-Based Approach for Prevention and Management of Drug Shortages is a hands-on, interactive course based on PDA’s Technical Report No. 68, Risk-Based Approach for Prevention and Management of Drug Shortages, that explores what controls can be established in the end-to-end product value chain to address drug shortage risks and proactively prevent them.
Be challenged to think creatively and in a risk-based manner about other practical solutions that can be leveraged beyond conventional solutions, such as collaboration with health authorities to expedite post-approval changes, short-term use of an alternate facility, activating short-term supply from an alternate source to address emergency needs and more.
During this course, you will learn to develop a Drug Shortage Risk Register and a Drug Shortage Prevention and Response Plan using examples and standard templates. Then, take home these practical risk-based triage tools and templates to proactively identify and manage your company's drug shortage risks.
Stay ahead of this growing global concern!
>> For more information and to register for the course, click here
